Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study Authors retain all rights in any ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback